Search research articles
Contact Us
Filters
Showing results (21-30 of 80) with videos related to
Page
of 8
Sort By:
Cancer Genetics and Cytogenetics
|
November 11, 2008
Methylation status of MGMT gene promoter in meningiomas
Paula de Robles, John McIntyre, Sanjog Kalra, et al.
Neuro-Oncology Practice
|
March 9, 2026
The CARING intervention for neuro-oncology family caregivers: Primary outcomes from an abbreviated randomized controlled trial
Maija Reblin, Steven K Sutton, Hyojin Choi, et al.
SAGE Open Medical Case Reports
|
August 30, 2021
Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature
Yolanda Piña, Brittany R Evernden, Nikhil Khushalani, et al.
Cancer Research
|
October 3, 2012
The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism
Prakash Chinnaiyan, Elizabeth Kensicki, Gregory Bloom, et al.
Molecular Oncology
|
February 5, 2013
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib
Anjali Singh, Xueqing Lun, Aarthi Jayanthan, et al.
Magnetic Resonance Imaging
|
April 17, 2010
Detection of T(2) changes in an early mouse brain tumor
Barbara Blasiak, Boguslaw Tomanek, Abedelnasser Abulrob, et al.
Journal of Neurology
|
November 22, 2019
Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma
Yolanda Piña, Michael J Fusco, Robert J Macaulay, et al.
Carcinogenesis
|
July 22, 2005
The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells
Yan Zhou, Jing Zhang, Qiang Liu, et al.
Molecular Cancer
|
April 15, 2014
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
Mingzhe Weng, Wei Gong, Mingzhe Ma, et al.
Neuro-Oncology
|
April 16, 2005
Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group
Sarah Kirby, Stan Z Gertler, Warren Mason, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 80) with videos related to
Sort By:
Page
of 8
Cancer Genetics and Cytogenetics
|
November 11, 2008
Methylation status of MGMT gene promoter in meningiomas
Paula de Robles, John McIntyre, Sanjog Kalra, et al.
Neuro-Oncology Practice
|
March 9, 2026
The CARING intervention for neuro-oncology family caregivers: Primary outcomes from an abbreviated randomized controlled trial
Maija Reblin, Steven K Sutton, Hyojin Choi, et al.
SAGE Open Medical Case Reports
|
August 30, 2021
Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature
Yolanda Piña, Brittany R Evernden, Nikhil Khushalani, et al.
Cancer Research
|
October 3, 2012
The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism
Prakash Chinnaiyan, Elizabeth Kensicki, Gregory Bloom, et al.
Molecular Oncology
|
February 5, 2013
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib
Anjali Singh, Xueqing Lun, Aarthi Jayanthan, et al.
Magnetic Resonance Imaging
|
April 17, 2010
Detection of T(2) changes in an early mouse brain tumor
Barbara Blasiak, Boguslaw Tomanek, Abedelnasser Abulrob, et al.
Journal of Neurology
|
November 22, 2019
Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma
Yolanda Piña, Michael J Fusco, Robert J Macaulay, et al.
Carcinogenesis
|
July 22, 2005
The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells
Yan Zhou, Jing Zhang, Qiang Liu, et al.
Molecular Cancer
|
April 15, 2014
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
Mingzhe Weng, Wei Gong, Mingzhe Ma, et al.
Neuro-Oncology
|
April 16, 2005
Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group
Sarah Kirby, Stan Z Gertler, Warren Mason, et al.
Page
of 8